164 results on '"Yossepowitch, Ofer"'
Search Results
2. MP46-16 MUSCLE INVASIVE BLADDER CANCER - SURVIVAL AND HEALTH CARE BURDEN IN PATIENTS TREATED WITH NON-CURATIVE INTENT
3. MP07-11 REAL WORLD MEDICATION PERSISTENCE IN TREATMENT OF WOMEN WITH OVERACTIVE BLADDER ACCORDING TO LARGE SCALE PRESCRIPTION CLAIMS DATA
4. PD57-04 MRI-BASED PI-RADS SCORE PREDICTS ISUP UPGRADING AND ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN MEN WITH BIOPSY ISUP 1 PROSTATE CANCER
5. MP41-06 THE ROLE OF MALNUTRITION UNIVERSAL SCREENING TOOL IN PREDICTING OUTCOMES AFTER RADICAL CYSTECTOMY
6. MP36-17 NON-CONTRAST COMPUTED TOMOGRAPHY FOR SUSPICION OF OBSTRUCTING UROLITHIASIS IN THE EMERGENCY ROOM: PATTERN AND YIELD
7. MP02-10 LONG-TERM USE OF DOUBLE INTERNAL STENTS FOR EXTRINSIC MALIGNANT URETERAL OBSTRUCTION
8. Editorial Comment
9. PD16-10 RESIDENCY BY FOOT: ASSESSMENT OF WORKING SHIFT PHYSICAL EFFORT BY COUNTING STEPS
10. MP22-09 DIAGNOSTIC NEEDLE BIOPSIES IN RENAL MASSES: PATIENT AND PHYSICIAN PERSPECTIVES
11. PD11-08 COLOR AND MORPHOLOGY COMBINATION FOR DETECTION OF LOW-GRADE UROTHELIAL CANCER CELLS: MULTI-CENTER VALIDATION STUDY
12. PD11-12 URINARY TRACT INFECTION AFTER URINARY DIVERSION – DIFFERENT PATTERNS OF OCCURRENCE IN PATIENTS WITH ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER
13. PD17-12 PATIENT COMPLIANCE WITH INTRAVESICAL MAINTENANCE PROTOCOLS FOR NON-MUSCLE INVASIVE BLADDER CANCER
14. PD23-03 A NOVEL URINE CYTOLOGY STAIN FOR THE DETECTION AND MONITORING OF UROTHELIAL CARCINOMA
15. A Novel Urine Cytology Stain for the Detection and Monitoring of Bladder Cancer
16. PD14-10 CURRENT TRENDS IN MANAGEMENT OF HIGH-RISK PROSTATE CANCER IN EUROPE: RESULTS OF A WEB-BASED SURVEY BY THE PROSTATE CANCER WORKING GROUP OF THE YOUNG ACADEMIC UROLOGISTS WORKING PARTY OF THE EUROPEAN ASSOCIATION OF UROLOGY
17. 440 LOW DOSE ORAL DESMOPRESSIN FOR THE TREATEMNT OF NOCTURNAL ENURESIS IN PATIENTS AFTER RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION – A PROSPECTIVE CASE CONTROL STUDY
18. 1425 URINARY TRACT INFECTION IN PATIENTS WITH AN ORTHOTOPIC NEOBLADDER
19. Resection of Ureteral Orifice During Transurethral Resection of Bladder Tumor: Functional and Oncologic Implications
20. An Ileal Conduit—Who Takes Care of the Stoma?
21. 534 RESECTION OF URETERAL ORIFICES DURING TRANSURETHRAL RESECTION OF BLADDER TUMORS - FUNCTIONAL AND ONCOLOGICAL IMPLICATIONS
22. Urothelial Carcinoma of the Bladder in Patients on Hemodialysis: Clinical Characteristics and Oncological Outcomes
23. 1077 EMPIRIC ANTIBIOTICS FOR AN ELEVATED PSA A RANDOMIZED, PROSPECTIVE MULTI-INSTITUTIONAL TRIAL
24. External Validation of a Biomarker Based Pre-Cystectomy Algorithm to Predict Nonorgan Confined Urothelial Cancers
25. Testicular Prostheses for Testis Cancer Survivors: Patient Perspectives and Predictors of Long-Term Satisfaction
26. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
27. Persistent Vesicourethral Anastomotic Leak After Radical Prostatectomy: A Novel Endoscopic Solution
28. 1351 CLINICALLY UNCONFIRMED POSITIVE URINE CYTOLOGY – ONCOLOGICAL IMPLICATIONS OVER LONG TERM FOLLOW-UP
29. Holmium Laser Endoureterotomy for Benign Ureteral Stricture: A Single Center Experience
30. Multifocality in Testicular Germ Cell Tumors
31. Risk Score and Metastasectomy Independently Impact Prognosis of Patients With Recurrent Renal Cell Carcinoma
32. Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes
33. CONCOMITANT MICROSCOPIC TUMOR DEPOSITS ACCOMPANYING OVERT TESTICULAR CANCER
34. PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY FOR PATIENTS TREATED IN THE PROSTATE- SPECIFIC ANTIGEN ERA
35. DECLININING BASELINE GFR IMPACTS SURVIVAL IN PATIENTS UNDERGOING PARTIAL OR RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS
36. ONCOLOGIC OUTCOMES FOR PATIENTS WITH POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY
37. PREDICTING RISK OF PROSTATE CANCER-SPECIFIC MORTALITY BASED ON CLINICOPATHOLOGIC FEATURES AT RADICAL PROSTATECTOMY
38. Positive Surgical Margins in Soft Tissue Following Radical Cystectomy for Bladder Cancer and Cancer Specific Survival
39. A Novel Resectoscope for Transurethral Resection of Bladder Tumors and the Prostate
40. Advanced but Not Localized Prostate Cancer is Associated With Increased Oxidative Stress
41. Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods
42. 377: Radical Prostatectomy for Clinically Localized high-risk Prostate Cancer: Critical Analysis of Risk-Assessment Methods
43. 1728: A Novel Resectoscope for Transurethral Resection of Bladder Tumors and the Prostate
44. 1725: Early Reinstitution of Aspirin after Prostate and Transurethral Bladder Surgeries is not associated with Increased Incidence of Postoperative Bleeding - A Prospective Randomized Trial
45. Use of Urinary Biomarkers for Bladder Cancer Surveillance: Patient Perspectives
46. Temporary Renal Ischemia During Nephron Sparing Surgery is Associated With Short-Term but Not Long-Term Impairment in Renal Function
47. Prediagnosis Prostate Specific Antigen Velocity is Associated With Risk of Prostate Cancer Progression Following Brachytherapy and External Beam Radiation Therapy
48. Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Instillations in Steroid Treated and Immunocompromised Patients
49. 719: Renal Cell Carcinoma Recurrence Following Nephrectomy for Localized Disease: Predicting Survival from Time of Recurrence
50. 1602: Time from Prostate Biopsy to Radical Prostatectomy does Not Impact Surgical Difficulty or Efficacy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.